American Diabetes Association
Standards of Care 2024
This guideline holds 256 pages.
Summary
Comprehensive annual update to diabetes standards. Highlights include expanded GLP-1 RA and SGLT2-i indications independent of HbA1c, tirzepatide approved for weight management, and revised HbA1c targets based on individualized patient goals. Technology integration (CGM, automated insulin delivery) is now standard of care.
How the evidence was graded
Grading system
Class I–III
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- American Diabetes Association
- Published
- 2024
- Region
- USA
- Language
- English
- Grading system
- Class I–III
Keywords
- Type 2 Diabetes
- GLP-1
- SGLT2i
- Tirzepatide
- CGM
- HbA1c targets
More in endocrinology and metabolism
- Diabetic kidney disease (Update 2026) : Guidelines in a collaboration of the Austrian Diabetes Association and the Austrian Society of NephrologyAustrian Diabetes Association and Austrian Society of Nephrology · 2026
- Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of EndocrinologyWorld Health Organization · 2026
